Paolo Tarantino Joins McGill University as Visiting Professor in Oncology

Early Life and Education

• Originally from Italy
• Pursued foundational medical training at the University of Milan
• Obtained MD with distinction
• Received PhD in Clinical and Experimental Oncology
• Focused on molecular drivers of breast cancer and mechanisms of resistance to targeted therapies
• Demonstrated strong commitment to translational research

Career and Leadership Roles

• Serving as an Advanced Fellow at Dana-Farber Cancer Institute, Boston
• Collaborates with world-renowned leaders in breast cancer research
• Mentors young oncologists and residents
• Co-leads several early-phase clinical studies
• Frequently participates in international oncology boards and academic forums

Research Contributions

• Main areas of research include HER2-low breast cancer biology and treatment
• Novel antibody-drug conjugates (ADCs)
• Tumor heterogeneity and resistance pathways
• Integration of genomics into clinical practice

Recognition and Awards

• ESMO Translational Research Fellowship Award
• Dana-Farber Excellence in Clinical Research Award
• Young Investigator Award from the European School of Oncology

A New Chapter at McGill University

• Focusing on expanding cross-institutional collaborations between McGill’s oncology department and Dana-Farber
• Developing joint research programs
• Mentoring early-career oncologists
• Fostering innovation in translational oncology

Looking Ahead

• Strengthens McGill University’s position as a hub for groundbreaking cancer research and education
• Promotes a global approach to oncology through collaboration
• Translates scientific progress into meaningful improvements for patients worldwide